Bank Of New York Mellon Corp Igm Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$13.74 - $25.76 $907,334 - $1.7 Million	66,036 New	66,036 $907 Million
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $1.04 Million - $1.75 Million	67,132 New	67,132 $1.14 Million
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $497,002 - $870,559	32,231 Added 94.48%	66,345 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$13.27 - $25.5 $93,779 - $180,208	7,067 Added 26.13%	34,114 $616,000
Q1 2022 May 11, 2022	BUY	$13.42 - $29.73 $9,769 - $21,643	728 Added 2.77%	27,047 $723,000
Q4 2021 Feb 11, 2022	SELL	$27.59 - $66.39 $88,094 - $211,983	-3,193 Reduced 10.82%	26,319 $772,000
Q3 2021 Nov 12, 2021	SELL	$65.76 - $90.65 $9,074 - $12,509	-138 Reduced 0.47%	29,512 $1.94 Million
Q2 2021 Aug 11, 2021	SELL	$57.98 - $96.6 $199,567 - $332,497	-3,442 Reduced 10.4%	29,650 $2.47 Million
Q1 2021 May 13, 2021	BUY	$71.56 - $121.23 $6,798 - $11,516	95 Added 0.29%	33,092 $2.54 Million
Q4 2020 Feb 09, 2021	SELL	$47.41 - $115.03 $127,864 - $310,235	-2,697 Reduced 7.56%	32,997 $2.91 Million
Q3 2020 Nov 12, 2020	SELL	$43.0 - $84.01 $3,397 - $6,636	-79 Reduced 0.22%	35,694 $2.63 Million
Q2 2020 Aug 12, 2020	BUY	$51.3 - $75.21 $876,306 - $1.28 Million	17,082 Added 91.39%	35,773 $2.61 Million
Q1 2020 May 06, 2020	BUY	$31.51 - $73.75 $97,050 - $227,150	3,080 Added 19.73%	18,691 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$17.25 - $49.51 $269,289 - $772,900	15,611 New	15,611 $595,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.